	Malnutrition Severity, Morphofunctional Assessment, and Survival in Patients with Lung Cancer: A Multicentre Prospective Cohort Study. Lung Rodríguez de Vera-Gómez P, Galindo-Gallardo M, González-Pacheco M, Carmona-Llanos A, Zarco-Martín MT, Palmas-Candia FX, Carmen Roque-Cuéllar MDC, Muñoz-Garach A, Muñoz-Jiménez C, Rebollo-Pérez MI, Mustieles V, Fernández-Jiménez R, Fernández-Soto ML, García-Almeida JM. PMID: 42595921 [PubMed - indexed for MEDLINE]
	TP53 Mutation and Tumor-Infiltrating Lymphocytes as Predictors of PD-1/PD-L1 Inhibitor Efficacy in PD-L1-High Advanced NSCLC. Cancer Rep (Hoboken) Yan H, Xu Q, Zheng Y, Shen M, Li D. PMID: 42595871 [PubMed - indexed for MEDLINE]
	Î”Average of long and short axis diameter on non-contrast CT is associated with major pathological response to neoadjuvant immunotherapy in resectable non-small cell lung cancer. Eur Radiol Liu J, Xie M, Liu Y, Shen J, Yao J, Bao X, Zhang X, Wu J, Xue X. PMID: 42595861 [PubMed - as supplied by publisher]
	Targeting the Ubiquitin-Proteasome System: An Emerging Paradigm for Overcoming Resistance to Targeted Therapy in Non-Small Cell Lung Cancer. Exp Cell Res Chen R, Zhu H, Zhou K, Xie J. PMID: 42595292 [PubMed - as supplied by publisher]
	Comparing Different Planning Strategies for Pencil Beam Scanning Carbon Ion Radiotherapy for Stage I Peripheral Non-Small Lung Cancer: Toward Optimized Clinical Decision-Making. Int J Radiat Oncol Biol Phys Lu Y, Chen J, Sheng Y, Wang W, Mao J. PMID: 42595262 [PubMed - as supplied by publisher]
	SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial. Cancer Cell Li ZM, Zhou Z, He ZY, Han L, Fang J, Sun HM, Liu HF, Wang MX, Liu YB, Qu XJ, Yao Y, Gong Y, Yu Y, Shi HQ, Wang Y, Su CX, Yang KY, Shang YH, Ruan J, Yuan XL, Zhang MJ, Luo H, Cui JW, Lin XY, Li MX, Lou HZ, Yang RX, Wu H, Wang XC, Dan M, Zhang LQ, Su YZ, Wan XC, Zou K, Yang YY, Lu S. PMID: 42594871 [PubMed - as supplied by publisher]
	The COMPASS-CAT risk assessment model for predicting in-hospital venous thromboembolism in patients with breast, lung, colorectal, and ovarian cancer: A retrospective cohort study. J Int Med Res Wei H, Han W, Zhang X, Zhao J. PMID: 42593353 [PubMed - indexed for MEDLINE]
	Significant differences in volatile organic compounds and interleukin-12 (IL-12) serum levels between lung cancer patients and healthy controls: a cross-sectional study. Med Glas (Zenica) Nurandhini M, Setyawan UA, Listyoko AS, Djajalaksana S, Ponco Wardoyo AY. PMID: 42592994 [PubMed - indexed for MEDLINE]
	Diabetes Mellitus as an Independent Risk Factor for Unfavorable Prognosis in Patients With Small Cell Lung Cancer. Thorac Cancer Yan R, Yisilamu P, Ge Y, Zhou W. PMID: 42592881 [PubMed - indexed for MEDLINE]
	Redefining the Role of Chemotherapy and Targeted Cytotoxic Delivery in Lung Neuroendocrine Tumors. Thorac Cancer Laffi A, Lamberti G, La Salvia A. PMID: 42592685 [PubMed - indexed for MEDLINE]
	Superior sulcus tumor with vertebral invasion following initial diagnosis of cavitary lung disease: a case report. AME Case Rep Gritsiuta AI, Radfar P, Nishi SP, Petrov RV. PMID: 42592347 [PubMed]
	Tumor-SAM: Segment Anything Model for Semi-automatic Lung Tumor Segmentation in CT. Proc SPIE Int Soc Opt Eng Xie L, Tong Y, Wu C, Torigian DA, Udupa JK, Wan Y. PMID: 42592330 [PubMed]
	Prognostic value of gut microbiota-derived metabolites in non-small cell lung cancer: a retrospective cohort study of overall survival. Transl Cancer Res Pan H, Chen X, Wu W, Wang M, Wang Y. PMID: 42591787 [PubMed]
	Soluble immune checkpoints in lung cancer: linking prognostic signatures to immunotherapy response - a meta-analysis. Front Immunol Rotariu LM, Alexa-Stratulat T, Tanasa R, Pavel-Tanasa M. PMID: 42591702 [PubMed - indexed for MEDLINE]
	Consolidative thoracic radiotherapy following first-line chemo-immunotherapy in extensive-stage small-cell lung cancer: A systematic review and meta-analysis. Ther Adv Med Oncol Canaslan K, Kahraman EG, Öztop , Güven DC. PMID: 42591674 [PubMed]
	FGFR1 copy number gain is independently associated with shorter progression-free survival in advanced lung squamous cell carcinoma treated with first-line immune checkpoint inhibitor-based therapy. Front Immunol Mu S, Li X, Sun Y, Yu Y. PMID: 42591661 [PubMed - indexed for MEDLINE]
	Clinicopathological characteristics and prognosis of pulmonary spindle cell carcinoma: a population-based retrospective study using SEER data. Transl Cancer Res Zhuang L, Gao J, Zhang Y, Lin J. PMID: 42591587 [PubMed]
	Global research trends and thematic evolution in neoadjuvant therapy and surgery for non-small cell lung cancer: a bibliometric and scientometric analysis. Front Immunol Wu X, Zhao W, Cheng X, Li M, Xu H, Cao D. PMID: 42591551 [PubMed - indexed for MEDLINE]
	Dietary spermidine intake is not associated with prostate cancer incidence or prostate cancer-specific mortality: findings from the prostate, lung, colorectal, and ovarian cancer screening trial. Front Nutr Wang G, Lin J, Lin Z, Jian J, Xu J, Xie J, Liu S, Chen Q, Zhong D. PMID: 42591195 [PubMed]
	Endobronchial Intratumoral Immuno- and Gene Therapies in Lung Cancer: Mechanisms of Local Delivery, Systemic Immune Effects, and Global Feasibility. Int J Mol Sci Olteanu M, Andrei GM, Cioboat, R. PMID: 42589640 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 162274

Page 1 of 8114



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy